Core Education

Our Core Education articles help you understand your cancer so you are equipped to find a good care team, ask appropriate questions, and become your own best advocate.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

What is Pancytopenia? Symptoms, Causes, & Treatments

October 11, 2024

Are your blood counts low? It may be pancytopenia. Learn about its causes and treatments.

What are Bispecific Antibodies for Follicular Lymphoma?

October 11, 2024

What are bispecific antibodies, and when are they used to treat follicular lymphoma? Learn answers to these questions and more!

How Can Large B-Cell Lymphoma Affect the Lungs?

October 07, 2024

Diffuse Large B-cell Lymphoma (DLBCL) can begin in or spread to the lungs. The signs and symptoms are non-specific, which can make diagnosis difficult.

New Treatment For Follicular Lymphoma: Understanding BTK Inhibitors

September 13, 2024

A new and promising drug combination to treat follicular lymphoma

Chemotherapy-Free Regimens for DLBCL

August 06, 2024

Chemo-free regimens can benefit patients for whom chemotherapy did not work or patients unable to receive intensive treatment.

What is R-CHOP?

July 17, 2024

R-CHOP is a type of chemoimmunotherapy consisting of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone.

What Are Early Signs of Follicular Lymphoma?

July 15, 2024

Some patients with follicular lymphoma have no symptoms for many years. When symptoms do arise, they are similar to other types of lymphoma.

Everything You Need to Know About DLBCL

July 03, 2024

All of the information you need to know about DLBCL, symptoms, treatment, and staging.

Frequently Asked Questions About Lymphoma: B vs. T Cells

June 27, 2024

Understand the difference between B-cell and T-cell lymphomas, discover the most aggressive types, and learn about curability rates.

Non-Hodgkin Lymphoma: Understanding Your Diagnosis (Aggressive vs. Indolent)

June 24, 2024

NHL can be subdivided based on whether it is aggressive or indolent. Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma (NHL).